FINANCIAL STATEMENT RESTATEMENT (Details 2) - USD ($)	3 Months Ended
	Jan. 31, 2025	Jan. 31, 2024
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Beginning Additional Paid-in Capital - Balance at October 31, 2023	$ 43,611,365
Beginning Accumulated Deficit - Balance at October 31, 2023	(45,434,694)
Net loss for the three months ended January 31, 2024	5,461,393	$ (507,073)
Ending Additional paid in capital - - Balance at January 31, 2024	49,062,408
Ending Accumulated Deficit - Balance at January 31, 2024	$ (50,896,087)
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Beginning Additional Paid-in Capital - Balance at October 31, 2023		41,079,902
Beginning Accumulated Deficit - Balance at October 31, 2023		(41,609,945)
Beginning Total Stockholders Deficit - Balance at October 31, 2023		$ (92,201)
Series A preferred issued pursuant to patent agreement, shares		10,000,000
Series A preferred issued pursuant to patent agreement, amount		$ 10,000
Net loss for the three months ended January 31, 2024		(522,717)
Ending Additional paid in capital - - Balance at January 31, 2024		41,171,311
Ending Accumulated Deficit - Balance at January 31, 2024		(42,132,662)
Ending Total Stockholders Deficit - Balance at January 31, 2024		(489,418)
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Beginning Additional Paid-in Capital - Balance at October 31, 2023		390,275
Beginning Accumulated Deficit - Balance at October 31, 2023		(486,159)
Beginning Total Stockholders Deficit - Balance at October 31, 2023		$ (100,884)
Series A preferred issued pursuant to patent agreement, shares		(5,000,000)
Series A preferred issued pursuant to patent agreement, amount		$ (5,000)
Net loss for the three months ended January 31, 2024		15,644
Ending Additional paid in capital - - Balance at January 31, 2024		390,275
Ending Accumulated Deficit - Balance at January 31, 2024		(470,515)
Ending Total Stockholders Deficit - Balance at January 31, 2024		(85,240)
As Restated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Beginning Additional Paid-in Capital - Balance at October 31, 2023		41,470,177
Beginning Accumulated Deficit - Balance at October 31, 2023		(42,096,104)
Beginning Total Stockholders Deficit - Balance at October 31, 2023		$ (193,085)
Series A preferred issued pursuant to patent agreement, shares		5,000,000
Series A preferred issued pursuant to patent agreement, amount		$ 5,000
Net loss for the three months ended January 31, 2024		(507,073)
Ending Additional paid in capital - - Balance at January 31, 2024		41,561,586
Ending Accumulated Deficit - Balance at January 31, 2024		(42,603,177)
Ending Total Stockholders Deficit - Balance at January 31, 2024		$ (574,658)